trending Market Intelligence /marketintelligence/en/news-insights/trending/ssnngjc3witjfg8grvv-iq2 content esgSubNav
In This List

OncoSil Medical closes institutional placement

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022

Blog

Insight Weekly: CEO pay jumps; yield curve inversion deepens; wind giants lift turbine prices


OncoSil Medical closes institutional placement

OncoSil Medical Ltd. closed the first tranche of its previously announced non-underwritten institutional placement of 106.1 million shares.

The company issued 72.7 million shares at 12 Australian cents each in the first tranche, raising A$8.7 million.

OncoSil will issue 33.3 million shares at the same price under the second tranche, for proceeds of about A$4 million. The second tranche is subject to shareholder approval at a May 4 meeting.

Wilsons Corporate Finance Ltd. is managing the institutional placement.

Australia-based OncoSil is a late-stage medical device company that develops localized cancer treatments.